Front Row Advisors LLC Takeda Pharmaceutical CO LTD Transaction History
Front Row Advisors LLC
- $271 Million
- Q3 2024
A detailed history of Front Row Advisors LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Front Row Advisors LLC holds 145 shares of TAK stock, worth $1,899. This represents 0.0% of its overall portfolio holdings.
Number of Shares
145
Previous 460
68.48%
Holding current value
$1,899
Previous $5,000
60.0%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding TAK
# of Institutions
337Shares Held
73.9MCall Options Held
1.96MPut Options Held
165K-
Capital Research Global Investors Los Angeles, CA13.1MShares$172 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.35MShares$70.1 Million0.01% of portfolio
-
Mondrian Investment Partners LTD London, X05.09MShares$66.7 Million1.21% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA4.64MShares$60.7 Million0.05% of portfolio
-
Goldman Sachs Group Inc New York, NY4.56MShares$59.7 Million0.01% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $40.7B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...